CMS Extends GENEROUS Model Application to Lower Drug Costs
CMS extended the application deadline for prescription drug manufacturers to apply for the GENErating cost Reductions fOr U.S. Medicaid (“GENEROUS”) Model. The GENEROUS Model was designed to lower drug spending in Medicaid and improve quality of care and health outcomes by increasing access to medications. The extension from March 31, 2026 to April 30, 2026 provides more drug manufacturers the opportunity to join the Model.
Two Physicians Added to CDC’s Advisory Committee on Immunization Practices
HHS and CDC announced the appointment of Sean G. Downing, M.D., and Angelina Farella, M.D., to the CDC Advisory Committee on Immunization Practices (“ACIP”).